Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Synovial Fibroblasts
100%
Invasive Properties
100%
Rheumatoid Arthritis
100%
Synoviocytes
100%
Fibroblast-like
100%
Rapamycin
88%
Phosphorylation
22%
MTOR Inhibitor
22%
4E-BP1
22%
Lamellipodia
22%
P70S6K
22%
DA Rats
22%
Pristane-induced Arthritis
22%
Villin
22%
Ezrin
22%
Histologic
11%
Gene Expression
11%
Signaling Pathway
11%
Immunofluorescence
11%
Cell Lysate
11%
Dimethyl Sulfoxide
11%
Synovial Tissue
11%
Rapamycin Treatment
11%
Rheumatoid Arthritis Patients
11%
Supernatant
11%
Actin Filaments
11%
Actin Reorganization
11%
Blood Type
11%
Matrix Metalloproteinase Activity
11%
Invasive Cancer
11%
Articular Damage
11%
Rheumatoid Arthritis Treatment
11%
Agouti
11%
Matrigel Invasion Assay
11%
Immunology and Microbiology
Inflammatory Arthritis
100%
Sirolimus
100%
Fibroblast-Like Synoviocyte
100%
Fibroblast
100%
Arthritis
22%
Dark Agouti Rat
22%
Filopodia
22%
Cell Lysate
11%
Immunofluorescence
11%
Actin
11%
Supernatant
11%
Actin Filament
11%
mTOR Signaling
11%
Agouti
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Actin
22%
Dark Agouti Rat
22%
Pristane-Induced Arthritis
22%
Villin
22%
Ezrin
22%
Mammalian Target of Rapamycin Inhibitor
11%
Dimethyl Sulfoxide
11%
Matrix Metalloproteinase
11%
Agouti
11%
Tumor Invasion
11%
Matrigel
11%
Biochemistry, Genetics and Molecular Biology
Mammalian Target of Rapamycin
100%
Fibroblast
100%
Actin
20%
Filopodia
20%
Dark Agouti Rat
20%
Ezrin
20%
Villin
20%
Cell Lysate
10%
Immunofluorescence
10%
Matrix Metalloproteinase
10%
mTOR Signaling
10%
Dimethyl Sulfoxide
10%
Supernatant
10%
Agouti
10%